P.N. Munster

A phase I dose-escalation and dose-expansion study of brontictuzumab in subjects with selected solid tumors

Renata Ferrarotto, Gail Eckhardt, Akash Patnaik et al. · Annals of Oncology · 2018 · 132 citations · Full text

Phase II study of single-agent bosutinib, a Src/Abl tyrosine kinase inhibitor, in patients with locally advanced or metastatic breast cancer pretreated with chemotherapy

Mario Campone, Igor Bondarenko, Stephen Brincat et al. · Annals of Oncology · 2011 · 103 citations · Full text

Metastatic Breast Cancer, Oncology, Breast Oncology +8

Phase II Trial of Tipifarnib plus Neoadjuvant Doxorubicin-Cyclophosphamide in Patients with Clinical Stage IIB-IIIC Breast Cancer

Joseph A. Sparano, Stacy L. Moulder, Aslamuzzaman Kazi et al. · Clinical Cancer Research · 2009 · 74 citations · Full text

Results of a phase 1 trial combining ridaforolimus and MK-0752 in patients with advanced solid tumours

Sarina A. Piha‐Paul, P.N. Munster, Antoine Hollebecque et al. · European Journal of Cancer · 2015 · 73 citations

Surgical Oncology, Medicine, Cancer Management +8

Targeted Inhibition of Farnesyltransferase in Locally Advanced Breast Cancer: A Phase I and II Trial of Tipifarnib Plus Dose-Dense Doxorubicin and Cyclophosphamide

Joseph A. Sparano, Stacy L. Moulder, Aslamuzzaman Kazi et al. · Journal of Clinical Oncology · 2006 · 66 citations · Full text